This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RABBIT ANTI RAT GLUTAMATE RECEPTOR 1 (C-TERMINAL)
catalog :
4670-5107
quantity :
50 µg
price :
614 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
rat
application :
western blot, immunoprecipitation
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
Region :
(C-TERMINAL)
ProductCode :
4670-5107
Description :
RABBIT ANTI RAT GLUTAMATE RECEPTOR 1 (C-TERMINAL)
Specificity :
GluR1
TargetSpecies :
Rat
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
C,WB,IP
ApplicationTypes :
Western Blotting,Immunohistology - Frozen,Immunoprecipitation
Cross Reactivities :
Monkey,Human,Hamster
Quantity :
50 µg
Quantity Value :
50
Quantity Type :
µg
GO Accessions :
GO:0071445,GO:0071407,GO:0071375,GO:0071363,GO:0071359,GO:0071230,GO:0060992,GO:0051602,GO:0050806,GO:0048167,GO:0045838,GO:0045211,GO:0043198,GO:0043197,GO:0043025,GO:0042803,GO:0042220,GO:0035249,GO:0032355,GO:0032279,GO:0031698,GO:0031681,GO:0031623,GO:0031594,GO:0031489,GO:0031267,GO:0030165,GO:0030054,GO:0021510,GO:0019901,GO:0019717,GO:0019228,GO:0046685,GO:0014069,GO:0010226,GO:0042493,GO:0008328,GO:0008179,GO:0007616,GO:0005789,GO:0005769,GO:0005234,GO:0051018,GO:0004970,GO:0005829,GO:0001965,GO:0001919
GOTerms :
G-alpha protein subunit binding,PKA binding,protein kinase A anchoring activity,ER membrane,adenylyl cyclase binding,drug resistance,drug susceptibility/resistance,GO:0017035,post synaptic density,post-synaptic density,arsenate sensitivity/resistance,response to arsenic,generation of action potential,DHR-domain binding,GLGF-domain binding,G-beta protein subunit binding,beta-2 adrenergic receptor ligand,response to E2 stimulus,dimerization activity,neuron cell body,neuronal cell soma,dendrite spine,post-synaptic membrane,activation of membrane potential,stimulation of membrane potential,up regulation of membrane potential,upregulation of membrane potential,up-regulation of membrane potential,activation of synaptic transmission,stimulation of synaptic transmission,up regulation of synaptic transmission,upregulation of synaptic transmission,up-regulation of synaptic transmission,response to electricity,cellular response to amino acid,cellular response to double-stranded RNA,cellular response to polypeptide hormone stimulus,cellular response to organic cyclic substance
Uniprot Accessions :
P19490
Gene :
Gria1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=50592
Published Synonyms :
GLUTAMATE RECEPTOR 1
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
Ig concentration 1 mg/ml
Product Form :
Purified Ig - liquid
PriceGBP :
439
PriceEUR :
614
PriceUSD :
614 USD
PriceCHF :
668
PriceSEK :
6693
PriceNOK :
6726
PriceDKK :
4578
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.